Impax Laboratories Inc. (Nasdaq: IPXL) named Paul M. Bisaro to the position of president and chief executive officer. Shares of the specialty pharmaceutical leaped $3.45 to close at $12.70.
Impax Laboratories names CEO
March 27, 2017 at 18:10 PM EDT